SCL 📈 Stepan - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8585861003
SCL: Surfactants, Polymers, Polyurethane, Emulsifiers, Flavors, Solubilizers, Chemicals
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois. Web URL: https://www.stepan.com
Additional Sources for SCL Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SCL Stock Overview
Market Cap in USD | 1,635m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1992-03-17 |
SCL Stock Ratings
Growth 5y | -54.8% |
Fundamental | 1.96% |
Dividend | 63.6% |
Rel. Strength Industry | -17188 |
Analysts | 3.5/5 |
Fair Price Momentum | 58.83 USD |
Fair Price DCF | 133.42 USD |
SCL Dividends
Dividend Yield 12m | 2.25% |
Yield on Cost 5y | 1.61% |
Annual Growth 5y | 7.48% |
Payout Consistency | 100.0% |
SCL Growth Ratios
Growth Correlation 3m | -23.7% |
Growth Correlation 12m | -82.5% |
Growth Correlation 5y | -59% |
CAGR 5y | -6.45% |
CAGR/Mean DD 5y | -0.30 |
Sharpe Ratio 12m | -1.24 |
Alpha | -49.17 |
Beta | 0.75 |
Volatility | 32.99% |
Current Volume | 273.5k |
Average Volume 20d | 115.5k |
What is the price of SCL stocks?
As of December 21, 2024, the stock is trading at USD 67.12 with a total of 273,517 shares traded.
Over the past week, the price has changed by -8.43%, over one month by -9.39%, over three months by -11.97% and over the past year by -25.79%.
As of December 21, 2024, the stock is trading at USD 67.12 with a total of 273,517 shares traded.
Over the past week, the price has changed by -8.43%, over one month by -9.39%, over three months by -11.97% and over the past year by -25.79%.
Is Stepan a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Stepan is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCL as of December 2024 is 58.83. This means that SCL is currently overvalued and has a potential downside of -12.35%.
Neither. Based on ValueRay Fundamental Analyses, Stepan is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 1.96 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCL as of December 2024 is 58.83. This means that SCL is currently overvalued and has a potential downside of -12.35%.
Is SCL a buy, sell or hold?
Stepan has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SCL.
Stepan has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SCL.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for SCL stock price target?
According to ValueRays Forecast Model, SCL Stepan will be worth about 63.7 in December 2025. The stock is currently trading at 67.12. This means that the stock has a potential downside of -5.05%.
According to ValueRays Forecast Model, SCL Stepan will be worth about 63.7 in December 2025. The stock is currently trading at 67.12. This means that the stock has a potential downside of -5.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 97 | 44.5% |
Analysts Target Price | 91 | 35.6% |
ValueRay Target Price | 63.7 | -5.1% |